About Istanbul Medeniyet University Medical Faculty
Istanbul Medeniyet University is a public university in Istanbul, Turkey. It was established on July 21, 2010. "Medeniyet" is the Turkish word for "civilization" or "culture".
Clinical Trials at Istanbul Medeniyet University Medical Faculty
During the past decade, Istanbul Medeniyet University Medical Faculty conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on
average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Istanbul Medeniyet University Medical Faculty"
#1 collaborator was "NSABP Foundation Inc" with 2 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "German Breast Group" with 1 trials as a collaborator and "Spanish Breast Cancer Research Group (SOLTI)" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were
collaborators in the rest 4 trials.
Clinical Trials Conditions at Istanbul Medeniyet University Medical Faculty
According to Clinical.Site data, the most researched conditions in "Istanbul Medeniyet University Medical Faculty" are
"Breast Cancer" (1 trials), "HER2-Positive Primary Breast Cancer" (1 trials), "Juvenile Idiopathic Arthritis" (1 trials), "Non-small Cell Lung Cancer" (1 trials) and "Residual Invasive Breast Cancer" (1 trials). Many other conditions were trialed in "Istanbul Medeniyet University Medical Faculty" in a lesser frequency.
Clinical Trials Intervention Types at Istanbul Medeniyet University Medical Faculty
Most popular intervention types in "Istanbul Medeniyet University Medical Faculty" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Abemaciclib" (1 trials), "CP-690,550 (tofacitinib)" (1 trials), "Carboplatin" (1 trials), "DS-8201a" (1 trials) and "EU-approved Avastin®" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Istanbul Medeniyet University Medical Faculty
The vast majority of trials in "Istanbul Medeniyet University Medical Faculty" are
4 trials for "All" genders.
Clinical Trials Status at Istanbul Medeniyet University Medical Faculty
Currently, there are NaN active trials in "Istanbul Medeniyet University Medical Faculty".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Istanbul Medeniyet University Medical Faculty,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Istanbul Medeniyet University Medical Faculty, 0 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".